{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q16236",
      "entity_text" : "Nrf2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The present study indicated that activation of Nrf2 dramatically mitigated pathological changes within the intestine and reduced the inflammatory response and apoptosis by inhibiting the NF-kappaB pathway, while Nrf2 antagonists have the opposite effect.",
  "reading_complete" : "2020-08-03T13:15:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T13:14:30Z",
  "trigger" : "reduced",
  "evidence" : [ "Nrf2 dramatically mitigated pathological changes within the intestine and reduced the inflammatory response and apoptosis by inhibiting the NF-kappaB" ],
  "pmc_id" : "5716448",
  "score" : 0
}